US Archives - Page 90 of 130 - European Medical Journal

Efficacy of Selpercatinib Beyond NSCLC Progression

Selpercatinib, a targeted RET kinase inhibitor, has demonstrated continued efficacy in treating RET fusion-positive non–small cell lung cancer (NSCLC) even after disease progression.

Study Links Early β-lactam Use to Lower Sepsis Deaths

A recent study sheds light on the timing of antibiotic administration in patients with suspected sepsis, suggesting that giving β-lactam antibiotics before vancomycin may lead to better outcomes.

Axial Spondyloarthritis More Severe in Black Americans

A recent study conducted across five centers in Shelby County, Tennessee, reveals concerning disparities in the diagnosis and severity of axial spondyloarthritis (axSpA) in Black Americans.

Global Consensus Forms on Low-Dose Oral Minoxidil

An international expert panel of 43 dermatologists has established an expert consensus on the off-label use of low-dose oral minoxidil (LDOM) for treating hair loss.

Breakthroughs in IgG4-Related Autoimmune Neuropathies

A recently published review article has shed light on significant breakthroughs in the understanding and treatment of IgG4-mediated autoimmune diseases, particularly in the realm of autoimmune neuropathies.

Functional Outcomes After Respiratory Failure Explored

Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.

Omega-3 Diet Reduces Prostate Cancer Progression

A recent Phase II clinical trial has revealed promising results for men with low-grade prostate cancer on active surveillance (AS).

VISIBLE Study Drives Diversity in Psoriasis Research

In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.

Dynamic Model Improves Migrant Tuberculosis Detection

Tuberculosis (TB) remains a persistent health concern among migrants to low-TB-incidence countries, including Canada.

Estrogen-Progesterone Therapy Linked to Autoimmune Risks

A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.